Luigi Francesco Iannone (Luigi F Iannone)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Cerebral Blood Flow

Epidermal Growth Factor Receptor

Cognitive Impairment

Genome Wide Identification

Top Venues

Journal of clinical medicine

Temperature (Austin, Tex.)

Cephalalgia : an international journal of headache

European journal of neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Albanese, Francesca Pescini, Chiara Di Bonaventura, Luigi Francesco Iannone, Silvia Bianchi, Anna Poggesi, Mario Bengala, Nicola Biagio Mercuri, Francesco De Cesaris
Long-Term Treatment with the Calcitonin Gene-Related Peptide Receptor Antagonist Erenumab in CADASIL: Two Case Reports. Journal of clinical medicine 13 (7) (2024)
Maria Albanese, Francesca Pescini, Chiara Di Bonaventura, Luigi Francesco Iannone, Silvia Bianchi, Anna Poggesi, Mario Bengala, Nicola Biagio Mercuri, Francesco De Cesaris
Long-Term Treatment with the Calcitonin Gene-Related Peptide Receptor Antagonist Erenumab in CADASIL: Two Case Reports. Journal of clinical medicine 13 (7) (2024)
Maria Albanese, Francesca Pescini, Chiara Di Bonaventura, Luigi Francesco Iannone, Silvia Bianchi, Anna Poggesi, Mario Bengala, Nicola Biagio Mercuri, Francesco De Cesaris
Long-Term Treatment with the Calcitonin Gene-Related Peptide Receptor Antagonist Erenumab in CADASIL: Two Case Reports. Journal of clinical medicine 13 (7) (2024)
Luigi Francesco Iannone, Andrea Burgalassi, Giulia Vigani, Giorgio Tabasso, Francesco De Cesaris, Alberto Chiarugi, Pierangelo Geppetti
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study. Cephalalgia : an international journal of headache 43 (4) (2023)
Valeria Caponnetto, Antonio Russo, Marcello Silvestro, Alessandro Tessitore, Roberto De Icco, Gloria Vaghi, Grazia Sances, Cristina Tassorelli, Carlo Baraldi, Flavia Lo Castro, Simona Guerzoni, Maria Pia Prudenzano, Adriana Fallacara, Martino Gentile, Raffaele Ornello, Agnese Onofri, Andrea Burgalassi, Alberto Chiarugi, Francesco De Cesaris, Antonio Granato, Alfonsina Casalena, Marina De Tommaso, Edoardo Mampreso, Paola Merlo, Gianluca Coppola, Stefania Battistini, Valentina Rebecchi, Innocenzo Rainero, Federica Nicoletta Sepe, Giorgio Dalla Volta, Simona Sacco, Pierangelo Geppetti, Luigi Francesco Iannone, null null
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study. CNS drugs (2023)
Luigi Francesco Iannone, Romina Nassini, Riccardo Patacchini, Pierangelo Geppetti, Francesco De Logu
Neuronal and non-neuronal TRPA1 as therapeutic targets for pain and headache relief. Temperature (Austin, Tex.) 10 (1) (2022)
Luigi Francesco Iannone, Francesco De Cesaris, Anita Ferrari, Silvia Benemei, Davide Fattori, Alberto Chiarugi
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine. Cephalalgia : an international journal of headache 42 (13) (2022)
Luigi Francesco Iannone, Romina Nassini, Riccardo Patacchini, Pierangelo Geppetti, Francesco De Logu
Neuronal and non-neuronal TRPA1 as therapeutic targets for pain and headache relief. Temperature (Austin, Tex.) 10 (1) (2022)
Luigi Francesco Iannone, Francesco De Cesaris, Pierangelo Geppetti
Emerging Pharmacological Treatments for Migraine in the Pediatric Population. Life (Basel, Switzerland) 12 (4) (2022)
Luigi Francesco Iannone, Davide Fattori, Silvia Benemei, Alberto Chiarugi, Pierangelo Geppetti, Francesco De Cesaris
Predictors of sustained response and effects of the discontinuation of anti-calcitonin gene related peptide antibodies and reinitiation in resistant chronic migraine. European journal of neurology 29 (5) (2022)
Luigi Francesco Iannone, Roberta Roberti, Gabriele Arena, Simone Mammone, Patrizia Pulitano, Giovambattista De Sarro, Oriano Mecarelli, Emilio Russo
Assessing knowledge and attitudes toward epilepsy among schoolteachers and students: Implications for inclusion and safety in the educational system. PloS one 16 (4) (2021)